Rossari Biotech Ltd
NSE:ROSSARI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (22.9), the stock would be worth ₹826.78 (62% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 14.2 | ₹511.35 |
0%
|
| 3-Year Average | 22.9 | ₹826.78 |
+62%
|
| 5-Year Average | 25 | ₹902.61 |
+77%
|
| Industry Average | 19.1 | ₹689.69 |
+35%
|
| Country Average | 23.3 | ₹840.03 |
+64%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₹27.8B
|
/ |
Jan 2026
₹2B
|
= |
|
|
₹27.8B
|
/ |
Mar 2026
₹2.1B
|
= |
|
|
₹27.8B
|
/ |
Mar 2027
₹2.5B
|
= |
|
|
₹27.8B
|
/ |
Mar 2028
₹2.9B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Rossari Biotech Ltd
NSE:ROSSARI
|
28.3B INR | 14.2 | 20.6 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83.6B USD | 24.8 | 32.6 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.7T JPY | 17.8 | 26.1 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
76B USD | 28.6 | 36.6 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 7.1 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
274.4B CNY | 18 | 20.8 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 21.6 | 24.3 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 37.9 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 45.6 | 61.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.5B USD | 13.4 | 15.6 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 14.2 | 17.5 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Rossari Biotech Ltd
Glance View
Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 451 full-time employees. The company went IPO on 2020-07-23. The firm provides customized solutions to industrial and production requirements of its customers through its diversified product portfolio. The company builds its expertise from textiles and has diversified into the animal health and nutrition, home, personal care and performance chemicals markets. The company offers a range of sustainable products for pre-treatment, dyeing, printing, finishing processes, and specialty chemicals. The firm provides specialty chemical solutions across the entire value-chain of the textile industry starting from thread, yarn and man-made fiber production to digital printing, fabric processing, dyeing auxiliaries and garment finishing range. The company develops product portfolio for its businesses of home, personal care and performance chemicals. The firm operates two manufacturing facilities at Silvassa and Dahej.
